Brain, Vol. 116, No. 3, 617-632, 1993
© 1993 Guarantors of Brain
research-article |
The mitochondrial DNA transfer RNALysA
G[8344] mutation and the syndrome of myoclonic epilepsy with ragged red fibres [MERRF]
Relationship of clinical phenotype to proporation of mutant mitochondrial DNA
1University Department of Clinical Neurology, Institute of Neurology London 2Department of Neurology, University of Nottingham Medical School Nottingham 3Wessex Neurological Centre, Southampton General Hospital Southampton, UK 4Child Health Department, Southampton General Hospital Southampton, UK
Correspondence to:
Correspondence to: Professor A. E. Harding, University Department of Clinical Neurology, Institute of Neurology, London WCIN 3BG, UK.
The mitochondrial DNA (mtDNA) transfer RNA (tRNA)Lys A
G(8344}8344 mutation was identified in seven patients. These patients and their relatives were assessed clinically; in one family the mutation was deduced to be present in four generations. The phenotype in index cases was consistent with the syndrome of myoclonus, epilepsy with ragged red fibres, with the core clinical features of myoclonus, ataxia and seizures. Amongst other features, progressive external ophthalmoplegia, Leigh's syndrome and stroke-like episodes were observed, well recognized in mitochondrial myopathies but novel manifestations of this genotype. Samples of blood and muscle were analysed for the proportion of mutant mtDNA using an oligonucleotide hybridization technique. The proportion of mutant mtDNA in blood was significantly greater in symptomatic than asymptomatic cases. Furthermore, the proportion of mutant mtDNA in blood correlated with age of onset of disease and clinical severity assessed by a simple scale. Study of disease associated with the tRNALys AG(8344]8344 mutation provides further insight into the pathogenesis and transmission of mitochondrial diseases. Quantification of the proportion of mtDNA in tissues demonstrates that this is a major factor determining the course of disease, but other, as yet unidentified factors are also likely to play a role.
Received August 19, 1992. Revised December 3, 1992. Accepted January 14, 1993.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Sato, K. Nakada, H. Shitara, A. Kasahara, H. Yonekawa, and J.-I. Hayashi Deletion-Mutant mtDNA Increases in Somatic Tissues but Decreases in Female Germ Cells With Age Genetics, December 1, 2007; 177(4): 2031 - 2037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. A. Kolesnikova, N. S. Entelis, C. Jacquin-Becker, F. Goltzene, Z. M. Chrzanowska-Lightowlers, R. N. Lightowlers, R. P. Martin, and I. Tarassov Nuclear DNA-encoded tRNAs targeted into mitochondria can rescue a mitochondrial DNA mutation associated with the MERRF syndrome in cultured human cells Hum. Mol. Genet., October 1, 2004; 13(20): 2519 - 2534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zeviani and S. Di Donato Mitochondrial disorders Brain, October 1, 2004; 127(10): 2153 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Tsao, G. Herman, D. R. Boue, T. W. Prior, W. D. Lo, J. F. Atkin, and J. Rusin Leigh Disease With Mitochondrial DNA A8344G Mutation: Case Report and Brief Review J Child Neurol, January 1, 2003; 18(1): 62 - 64. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Koga, Y. Akita, N. Takane, Y. Sato, and H. Kato Heterogeneous presentation in A3243G mutation in the mitochondrial tRNALeu(UUR) gene Arch. Dis. Child., May 1, 2000; 82(5): 407 - 411. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. F Chinnery, N. Howell, R. M Andrews, and D. M Turnbull Clinical mitochondrial genetics J. Med. Genet., June 1, 1999; 36(6): 425 - 436. [Abstract] [Full Text]
|
|
|
|
 |
|
 M G Hanna, I P Nelson, J A Morgan-Hughes, and N W Wood MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 512 - 517. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Zhou, A. Chomyn, G. Attardi, and C. A. Miller Myoclonic Epilepsy and Ragged Red Fibers (MERRF) Syndrome: Selective Vulnerability of CNS Neurons Does Not Correlate with the Level of Mitochondrial tRNAlys Mutation in Individual Neuronal Isolates J. Neurosci., October 15, 1997; 17(20): 7746 - 7753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lu, V. Planelles, X. Li, C. Palaniappan, B. Day, P. Challita-Eid, R. Amado, D. Stephens, D. B. Kohn, A. Bakker, et al. Inhibition of HIV-1 Replication Using a Mutated tRNALys-3 Primer J. Biol. Chem., June 6, 1997; 272(23): 14523 - 14531. [Abstract] [Full Text] [PDF]
|
|